Breaking News

GeoVax, ABL Partner to Advance cGMP Production of Vaccine Candidates

With cGMP facilities located in the U.S. and Europe, ABL will support GeoVax’s global development programs.

GeoVax Labs, Inc., a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, has executed a Master Services Agreement (MSA) with Advanced Bioscience Laboratories, Inc. (ABL) to support current Good Manufacturing Practices (cGMP) production of the company’s vaccine candidates, including GEO-MVA and GEO-CM04S1. ABL, a subsidiary of Institut Mérieux, is a contract development and manufacturing organization (CDMO) specialized in development and manuf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters